APA (7th ed.) Citation

Bitan, M., Or, R., Shapira, M. Y., Resnick, I. B., Gesundheit, B., Ackerstein, A., . . . Slavin, S. (2008). Time to engraftment following allogeneic stem cell transplantation is significantly longer in patients with myelodysplastic syndrome than with acute myeloid leukemia. Bone Marrow Transplantation, 41(1), 69. https://doi.org/10.1038/sj.bmt.1705878

Chicago Style (17th ed.) Citation

Bitan, M., R. Or, M. Y. Shapira, I. B. Resnick, B. Gesundheit, A. Ackerstein, S. Samuel, S. Elad, and S. Slavin. "Time to Engraftment Following Allogeneic Stem Cell Transplantation Is Significantly Longer in Patients with Myelodysplastic Syndrome than with Acute Myeloid Leukemia." Bone Marrow Transplantation 41, no. 1 (2008): 69. https://doi.org/10.1038/sj.bmt.1705878.

MLA (9th ed.) Citation

Bitan, M., et al. "Time to Engraftment Following Allogeneic Stem Cell Transplantation Is Significantly Longer in Patients with Myelodysplastic Syndrome than with Acute Myeloid Leukemia." Bone Marrow Transplantation, vol. 41, no. 1, 2008, p. 69, https://doi.org/10.1038/sj.bmt.1705878.